Literature DB >> 20038846

Chronic hepatitis C virus infection in children.

Neelam Mohan1, Regino P González-Peralta, Tomoo Fujisawa, Mei-Hwei Chang, Solange Heller, Paloma Jara, Deirdre Kelly, Giorgina Mieli-Vergani, Uzma Shah, Karen F Murray.   

Abstract

The importance of hepatitis C viral infection in the health care of children has grown in recent decades. More is now known about the epidemiology of this infection in children and the progression of disease in the pediatric age group, and the treatment options are increasing. In this review, we update readers on the state of our understanding of hepatitis C infection in children, provide the current recommendations for monitoring and treatment, and discuss emerging therapies.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20038846     DOI： 10.1097/MPG.0b013e3181c61995

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN： 0277-2116            Impact factor:   2.839


  16 in total

1.  Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV-1 infection 2015: optimizing health in preparation for adult life.

Authors:  A Bamford; A Turkova; H Lyall; C Foster; N Klein; D Bastiaans; D Burger; S Bernadi; K Butler; E Chiappini; P Clayden; M Della Negra; V Giacomet; C Giaquinto; D Gibb; L Galli; M Hainaut; M Koros; L Marques; E Nastouli; T Niehues; A Noguera-Julian; P Rojo; C Rudin; H J Scherpbier; G Tudor-Williams; S B Welch
Journal:  HIV Med       Date:  2015-02-03       Impact factor: 3.180

2.  Mechanisms of methods for hepatitis C virus inactivation.

Authors:  Stephanie Pfaender; Janine Brinkmann; Daniel Todt; Nina Riebesehl; Joerg Steinmann; Jochen Steinmann; Thomas Pietschmann; Eike Steinmann
Journal:  Appl Environ Microbiol       Date:  2014-12-19       Impact factor: 4.792

3.  Current treatment options and response rates in children with chronic hepatitis C.

Authors:  Stefan Wirth
Journal:  World J Gastroenterol       Date:  2012-01-14       Impact factor: 5.742

Review 4.  Treatment of hepatitis C in children: a systematic review.

Authors:  Jia Hu; Karen Doucette; Lisa Hartling; Lisa Tjosvold; Joan Robinson
Journal:  PLoS One       Date:  2010-07-13       Impact factor: 3.240

Review 5.  Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damage.

Authors:  Pamela Valva; Daniela A Ríos; Elena De Matteo; Maria V Preciado
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

Review 6.  Hepatitis C genotype 4: The past, present, and future.

Authors:  Tawhida Y Abdel-Ghaffar; Mostafa M Sira; Suzan El Naghi
Journal:  World J Hepatol       Date:  2015-12-08

7.  Sustained viral response and hematological adverse events in children with chronic hepatitis C.

Authors:  Alessandra Vigano; Valeria Manfredini; Gian Vincenzo Zuccotti
Journal:  Hepat Mon       Date:  2012-03-28       Impact factor: 0.660

8.  Hematological Adverse events and Sustained Viral Response in Children Undergoing Therapy for Chronic Hepatitis C Infection.

Authors:  Malgorzata Pawlowska; Malgorzata Pilarczyk; Anna Foksinska; Ewa Smukalska; Waldemar Halota
Journal:  Hepat Mon       Date:  2011-12-20       Impact factor: 0.660

9.  Serum apoptosis markers related to liver damage in chronic hepatitis C: sFas as a marker of advanced fibrosis in children and adults while M30 of severe steatosis only in children.

Authors:  Pamela Valva; Paola Casciato; Carol Lezama; Marcela Galoppo; Adrián Gadano; Omar Galdame; María Cristina Galoppo; Eduardo Mullen; Elena De Matteo; María Victoria Preciado
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

Review 10.  Treatment of children with chronic viral hepatitis: what is available and what is in store.

Authors:  Pietro Vajro; Claudio Veropalumbo; Sergio Maddaluno; Mariacarolina Salerno; Giancarlo Parenti; Claudio Pignata
Journal:  World J Pediatr       Date:  2013-08-09       Impact factor: 9.186
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.